The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((4'-(2-Hexylhydrazinecarbonyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide ID: ALA5174998
PubChem CID: 168273030
Max Phase: Preclinical
Molecular Formula: C22H29N3O2
Molecular Weight: 367.49
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCNNC(=O)c1ccc(-c2ccc(CNC(C)=O)cc2)cc1
Standard InChI: InChI=1S/C22H29N3O2/c1-3-4-5-6-15-24-25-22(27)21-13-11-20(12-14-21)19-9-7-18(8-10-19)16-23-17(2)26/h7-14,24H,3-6,15-16H2,1-2H3,(H,23,26)(H,25,27)
Standard InChI Key: TYHZHMRYNRDNRX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
2.8611 1.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5750 1.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2906 1.0423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1455 1.4498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4328 1.0384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7172 1.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7160 2.2739 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0033 1.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7123 1.4459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4279 1.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4279 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7123 -0.2126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0033 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1436 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1436 -1.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8593 -1.4439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5750 -1.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5750 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8593 0.2146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2888 -1.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0045 -1.0364 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7178 -1.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4335 -1.0384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7167 -2.2739 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0042 1.4570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7200 1.0463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4335 1.4610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
5 4 1 0
5 6 1 0
6 7 2 0
6 8 1 0
9 8 2 0
10 9 1 0
11 10 2 0
11 12 1 0
8 13 1 0
13 12 2 0
14 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
14 19 1 0
17 20 1 0
20 21 1 0
22 21 1 0
22 23 1 0
22 24 2 0
3 25 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.49Molecular Weight (Monoisotopic): 367.2260AlogP: 3.80#Rotatable Bonds: 10Polar Surface Area: 70.23Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.89CX LogP: 3.56CX LogD: 3.56Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.44Np Likeness Score: -0.76
References 1. Sun P, Wang J, Khan KS, Yang W, Ng BW, Ilment N, Zessin M, Bülbül EF, Robaa D, Erdmann F, Schmidt M, Romier C, Schutkowski M, Cheng AS, Sippl W.. (2022) Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties., 65 (24.0): [PMID:36449385 ] [10.1021/acs.jmedchem.2c01132 ]